Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Guangsheng Biopharmaceutical Co., Ltd

Clinical trials sponsored by Shanghai Guangsheng Biopharmaceutical Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Light therapy combo targets deadly bile duct cancer in new trial Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Light therapy combo targets deadly bile duct cancer in new trial

Disease control Recruiting now

This phase 2 trial is testing a new approach for people with advanced bile duct cancer that has caused a blockage. The treatment combines a light-activated drug (sodium porphyrin) with standard chemotherapy (gemcitabine and cisplatin). The goal is to see if this combination can h…

Phase 2 • Sponsor: Shanghai Guangsheng Biopharmaceutical Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 09:03 UTC